These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32692486)

  • 21. Improved Biosafety and Biosecurity Measures and/or Strategies to Tackle Laboratory-Acquired Infections and Related Risks.
    Peng H; Bilal M; Iqbal HMN
    Int J Environ Res Public Health; 2018 Nov; 15(12):. PubMed ID: 30501091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.
    Kimman TG; Smit E; Klein MR
    Clin Microbiol Rev; 2008 Jul; 21(3):403-25. PubMed ID: 18625678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biosafety and biosecurity in veterinary laboratories.
    Brass VH; Astuto-Gribble L; Finley MR
    Rev Sci Tech; 2017 Aug; 36(2):701-709. PubMed ID: 30152450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding Biosafety and Biosecurity in Ukraine.
    Houser RS; Koblentz GD; Lentzos F
    Health Secur; 2023; 21(1):70-80. PubMed ID: 36629857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biosafety and biosecurity as essential pillars of international health security and cross-cutting elements of biological nonproliferation.
    Bakanidze L; Imnadze P; Perkins D
    BMC Public Health; 2010 Dec; 10 Suppl 1(Suppl 1):S12. PubMed ID: 21143822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biosecurity. Synthetic biologists debate policing themselves.
    Service RF
    Science; 2006 May; 312(5777):1116. PubMed ID: 16728599
    [No Abstract]   [Full Text] [Related]  

  • 27. Regulation and management of the biosecurity for synthetic biology.
    Zeng X; Jiang H; Yang G; Ou Y; Lu S; Jiang J; Lei R; Su L
    Synth Syst Biotechnol; 2022 Jun; 7(2):784-790. PubMed ID: 35387231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surrogate strains of human pathogens for field release.
    Park S; Kim CH; Jeong ST; Lee SY
    Bioengineered; 2018 Jan; 9(1):17-24. PubMed ID: 28692329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Code of Conduct on Biosecurity for Biological Resource Centres: procedural implementation.
    Rohde C; Smith D; Martin D; Fritze D; Stalpers J
    Int J Syst Evol Microbiol; 2013 Jul; 63(Pt 7):2374-2382. PubMed ID: 23667143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reasons for and barriers to biosafety and biosecurity training in health-related organizations in Africa, Middle East and Central Asia: findings from GIBACHT training needs assessments 2018-2019.
    Rutebemberwa E; Aku FY; Zein EIKA; Bellali H
    Pan Afr Med J; 2020; 37():64. PubMed ID: 33244327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capacity and needs assessment of veterinary services in Vietnam in biosecurity, biosafety and One Health.
    Auplish A; Vu TTT; Pham Duc P; Green A; Tiwari H; Housen T; Stevenson MA; Dhand N
    PLoS One; 2024; 19(1):e0295898. PubMed ID: 38206956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biosafety, biosecurity, and bioethics.
    Resnik DB
    Monash Bioeth Rev; 2024 Jun; 42(1):137-167. PubMed ID: 39078602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Next-generation biocontainment systems for engineered organisms.
    Lee JW; Chan CTY; Slomovic S; Collins JJ
    Nat Chem Biol; 2018 Jun; 14(6):530-537. PubMed ID: 29769737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-evolution of physical and social sciences in synthetic biology.
    Trump BD; Cegan J; Wells E; Poinsatte-Jones K; Rycroft T; Warner C; Martin D; Perkins E; Wood MD; Linkov I
    Crit Rev Biotechnol; 2019 May; 39(3):351-365. PubMed ID: 30727764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Personalist Ontological Approach to Synthetic Biology.
    Gómez-Tatay L; Hernández-Andreu JM; Aznar J
    Bioethics; 2016 Jul; 30(6):397-406. PubMed ID: 26644292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety risks and ethical governance of biomedical applications of synthetic biology.
    Ou Y; Guo S
    Front Bioeng Biotechnol; 2023; 11():1292029. PubMed ID: 37941726
    [No Abstract]   [Full Text] [Related]  

  • 37. Emerging regulatory challenges of next-generation synthetic biology.
    Sheahan T; Wieden HJ
    Biochem Cell Biol; 2021 Dec; 99(6):766-771. PubMed ID: 34559974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What next for gain-of-function research in Europe?
    Fears R; ter Meulen V
    Elife; 2015 Dec; 4():. PubMed ID: 26716473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in Synthetic Biology and Biosafety Governance.
    Li J; Zhao H; Zheng L; An W
    Front Bioeng Biotechnol; 2021; 9():598087. PubMed ID: 33996776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic biology: Genetic kill switches--a matter of life or death.
    Osório J
    Nat Rev Genet; 2016 Feb; 17(2):67. PubMed ID: 26688199
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.